To further evaluate the therapeutic effect of tiliroside, another classical colitis model induced by TNBS in mice was used, and the results (Supplementary Figure S1) similarly showed that tiliroside dramatically improved survival rate, decreased MPO activity, lengthened the colons, and alleviated the histopathological damage in colons. This evidence concerns the gene MPO and colitis.